Slide 1Patents & Competitive Intelligence James L. Grant GLIST – Global Legal Information Science Team Pfizer Corporate Legal Patent Department La Jolla, CA, 92037…

Slide 1From NCIIA E-Team To Lifesaving Device Esther Klinger Michael E. Gorman Larry G. Richards University of Virginia Slide 2 A Case Study of Intelliject, Inc. Presented…

Slide 1PDUFA Legislative Update NORD Corporate Council Annual Meeting Paul Kim, Foley Hoag LLP May 15 2012 Slide 2 NORD Corporate Council | 2 Current Situation Overview of…

1. PharmacoPharmacoepidemiology??epidemiology?? AvinashAvinash VigiLant 2. ““A desire to take medicine is, perhaps, the greatA desire to take medicine is, perhaps, the…

1. CS207 #8, 18 Nov 2011 Gio WiederholdGates B12Drafts of reports received by 22Nov11 will receive feedback by 26Nov11 . Any make-up reports submitted by17Nov11 are marked…

1. BreakthroughTherapy DesignationChuck KemmererRegulatory Intelligence02March2014 2. Topics1) What is Breakthrough Therapy Designation?1) Legislative Implementation2) How…

Slide 1 Welcome 1 Current industrial Scenario With conduct to regulatory affairs Presented by: Swapnil N. Dharmshale M.Pharm-1st (Q.A). D.S.T.S Mandalâs College of Pharmacy,…

Slide 1 Pharmacoepidemiology Dr Lateef M Khan Introduction Application of epidemiological methods to the clinical use and effects of drugs in a large population is called…

1. Drug Regulation & Regulatory Authorities Dept. Of Quality Assurance & Regulatory Affairs L. J. Institute of Pharmacy, Ahmedabad. EXPERIMENT NO.: DATE: AIM: A)…

1 JENOPTIK Group. Thai FDAj Presentation 08.04.05 Pharmaceutical Cleanroom Commissioning, Certification, and Validation DQ, IQ, OQ, and PQ Pharmaceutical Cleanroom Commissioning,…